Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

2.10
Delayed Data
As of Jul 31
 -0.06 / -2.78%
Today’s Change
2.01
Today|||52-Week Range
17.20
-84.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues20.3M6.1M44.0K0.00
 
 
 
 
Depreciation And Amortization595.0K304.0K298.0K310.0K
 
 
 
 
 
 
Operating ExpensesGross Income19.7M5.8M---310.0K
 
 
 
 
General Expenses20.8M29.3M40.7M36.4M
 
 
 
 
 
Research And Development17.6M24.5M32.6M26.6M
 
 
 
 
 
Total Operating Expenses21.4M29.6M41.0M36.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-23.5M-40.9M-36.7M
 
 
 
 
 
Extraordinary Charge-1.1M-39.0K0.000.00
 
 
 
Interest Expense On Debt--185.0K1.1M1.2M
 
 
 
 
Other Expenses40.0K152.0K-39.0K-154.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.2M-23.5M-41.9M-38.0M
 
 
 
 
 
Net Income-2.2M-23.5M-41.9M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M262.0K3.0M4.1M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M262.0K3.0M4.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.20-$89.76-$13.84-$9.20
 
 
 
 
 
EPS Diluted-$0.74-$89.76-$13.84-$9.20